Beam Therapeutics Inc. announced the pricing of an underwritten offering of approximately 16.15 million shares of common stock at $28.48 each, alongside pre-funded warrants for nearly 1.4 million ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results